Skip to main content
Figure 9 | Arthritis Research & Therapy

Figure 9

From: Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

Figure 9

Action of uricase to catabolize uric acid to allantoin. Uricase (urate oxidase) gene expression and the depicted uricase reaction are lacking in humans, as discussed in the text. PEGylated recombinant uricase preparations are now under investigation for treatment of refractory hyperuricemia in gout, and have the potential to rapidly reduce ("de-bulk") tophus burden.

Back to article page